Key facts
- This page summarizes American Oncology Network, Inc.'s Form 4 filing for American Oncology Network, Inc. (AONC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 05 Jan 2024, 16:50.
American Oncology Network, Inc. - 03 Jan 2024 Form 4 Insider Report for American Oncology Network, Inc. (AONC)
- Reporting relationship
- Chief Medical Officer, Director
- Issuer ticker
- AONC
- Reported as of
- 03 Jan 2024
- Net transaction value
- $0
- Reporting owner signature
- Greg Imbrogno, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
American Oncology Network, Inc. filed Form 4 for American Oncology Network, Inc. (AONC) on 05 Jan 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AONC
transaction
Class A Common Stock
Award
- Transaction value
- $0
- Shares
- +9,893
- Change %
- Price
- $0.000000
- Shares after
- 9,893
- Date
- 03 Jan 2024
- Ownership
- Direct
AONC
holding
Class B Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 63,857
- Date
- 03 Jan 2024
- Ownership
- Stephen G. Divers, M.D., Trustee FBO Fred Divers Family Trust
* marks a reported price that did not pass the local price check.